Yuanfan Xiao

Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis

Jie Chen, Di Zhao, Lingyuan Zhang et al. · Drug Resistance Updates · 2024 · 25 citations

Medicine, Molecular Biology, Oncology +17

PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy

Di Zhao, Jing Zhang, Lingyuan Zhang et al. · Acta Pharmaceutica Sinica B · 2022 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +17

Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma

Jing Zhang, Di Zhao, Lingyuan Zhang et al. · Science China Life Sciences · 2023 · 16 citations

Medicine, Cell Biology, Oncology +12

AKT2S128/CCTαS315/319/323-positive cancer-associated fibroblasts (CAFs) mediate focal adhesion kinase (FAK) inhibitors resistance via secreting phosphatidylcholines (PCs)

Jie Chen, Lingyuan Zhang, Yuheng Zhu et al. · Signal Transduction and Targeted Therapy · 2024 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17

Co‐targeting FAK and Gli1 inhibits the tumor‐associated macrophages‐released CCL22‐mediated esophageal squamous cell carcinoma malignancy

Jie Chen, Yanmeng Zhu, Di Zhao et al. · MedComm · 2023 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +17